Caspr2 Encephalitis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CASPR2 Encephalitis is an autoimmune neurological disorder caused by antibodies targeting the Contactin-Associated Protein-like 2 (CASPR2), a member of the neurexin family that is crucial for the formation and maintenance of neuronal synapses[1], [2]. [2:1]
CASPR2 Encephalitis is recognized as one of the major autoimmune encephalitis syndromes[1:1]. It exists on a spectrum with Morvan syndrome, with overlapping clinical features. The condition is part of the voltage-gated potassium channel (VGKC) complex antibody spectrum, though the target antigen is actually CASPR2 rather than the potassium channel itself[2:2]. [3]
This disorder provides important insights into synaptic immunology and the role of axonal proteins in autoimmune neurological disease. Recent research indicates that publications on CASPR2 encephalitis have increased substantially, from 2 in 2010 to 54 in 2025, reflecting growing clinical awareness[^9]. [4]
Contactin-Associated Protein-like 2 (CASPR2) is encoded by the CNTNAP2 gene and is[1:2], [3:1]:
CASPR2 antibodies can also cause Morvan syndrome, characterized by[1:8], [3:4]:
Corticosteroids[1:12]
Plasma Exchange
Intravenous Immunoglobulin (IVIG)
Positive:
Negative:
CASPR2 encephalitis represents an important and increasingly recognized cause of autoimmune encephalitis. The condition is characterized by antibodies against CASPR2, a neuronal surface protein critical for synaptic function. Clinical manifestations include encephalopathy, seizures, movement disorders, and autonomic dysfunction. Diagnosis relies on detection of CASPR2 antibodies in serum or cerebrospinal fluid, with MRI findings that may include temporal and frontal lobe abnormalities. First-line immunotherapy with corticosteroids, plasma exchange, or IVIG leads to improvement in most patients, though some require second-line agents. The association with thymoma in a subset of patients underscores the importance of tumor screening. Ongoing research continues to refine our understanding of this condition's pathophysiology and optimal management strategies.
The study of Caspr2 Encephalitis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section highlights recent publications relevant to this disease.
Antibodies in Creutzfeldt-Jakob disease: A systematic review of patient characteristics, diagnostics, and clinical implications. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Severe sleep-related hypoventilation in antibody-positive and antibody-negative autoimmune encephalitis: an emergency. ↩︎ ↩︎ ↩︎
Morvan Syndrome Masquerading as Anxiety Disorder: A Case Report Highlighting the Importance of Recognizing Organic Signs in Psychiatric Settings. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Morvan syndrome associated with prominent Tau pathology: A clinicopathological case report. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎